In addition, SB204741 treatment effectively reversed palmitate-induced insulin resistance (Fig. 4e) and increased AMPK αThr172 phosphorylation in C2C12 myotubes (Fig. 4f), indicative of enhanced metabolic function. The gene discussed is PRKAA1; the disease is Insulin resistance.